New drug cocktail aims to attack blood cancer before transplant
NCT ID NCT04653246
Summary
This study is testing whether adding the experimental drug isatuximab to three standard chemotherapy drugs is safe and effective for people newly diagnosed with multiple myeloma. The trial involves 52 participants who are eligible for a stem cell transplant. Researchers want to see if this four-drug combination can better control the cancer before the transplant procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.